Seite - (000202) - in Biomedical Chemistry: Current Trends and Developments

Liguz-Lecznar, M. and J. Skangiel-Kramska (2007). Vesicular glutamate transporters (VGLUTs): the three musketeers of glutamatergic system. Acta Neurobiologica Experimental, 67(3), 207-218. Liu, B., M. Liao, et al. (2006). Ischemic insults direct glutamate receptor subunit 2-lacking AMPA receptors to synaptic sites. The Journal of Neurosciece, 26(20), 5309-5319. Lloyd-Jones, D., R. Adams, et al. (2009). Heart disease and stroke statistics - 2009 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation, 119(3), 480-486. Lo, E. H. (2008a). Experimental models, neurovascular mechanisms and translational issues in stroke research. Br J Pharmacol, 153 Suppl 1, S396-405. Lo, E. H. (2008b). A new penumbra: transitioning from injury into repair after stroke. Nature Medicine, 14(5), 497-500. Luscher, C., L. Y. Jan, et al. (1997). G protein-coupled inwardly rectifying K+ channels (GIRKs) mediate postsynaptic but not presynaptic transmitter actions in hippocampal neurons. Neuron, 19(3), 687-695. Marczynski, T. J. (1998). GABAergic deafferentation hypothesis of brain aging and Alzheimer’s disease revisited. Brain Research Bulletin, 45(4), 341-379. Mark, K. A., M. S. Quinton, et al. (2007). Dynamic changes in vesicular glutamate transporter 1 function and expression related to methamphetamine-induced glutamate release. The Journal of neuroscience, 27(25), 6823-6831. Mark, K. A., J. J. Soghomonian, et al. (2004). High-dose methamphetamine acutely activates the striatonigral pathway to increase striatal glutamate and mediate long-term dopamine toxicity. The Journal of neuroscience, 24(50), 11449-11456. Martin, R. L., H. G. Lloyd, et al. (1994). The early events of oxygen and glucose deprivation: setting the scene for neuronal death? Trends in Neuroscience, 17(6), 251-257. Mayer, M. (2004). Structure and function of glutamate receptors. Annuals of the New York Academy of Science, 1038, 125-130. McFarland, K., C. C. Lapish, et al. (2003). Prefrontal glutamate release into the core of the nucleus accumbens mediates cocaine-induced reinstatement of drug-seeking behavior. The Journal of euroscience, 23(8), 3531-3537. McIntire, S. L., R. J. Reimer, et al. (1997). Identification and characterization of the vesicular GABA transporter. Nature, 389(6653), 870-876. Meldrum, B. (2007). Status epilepticus: the past and the future. Epilepsia, 48 Suppl 8, 33-34. Meneses, A. (1999). 5-HT system and cognition. Neuroscience Biobehavior Review 23(8): 1111- 1125. Metzger, T. and E. Hildt (2011). Cognitive Enhancement. In J. Illes and B. J. Sahakian (Eds.), Oxford Handbook of Neuroethics (pp. 245-264). Oxford: Oxford University Pres. Meyer-Lindenberg, A. (2011). Neuroimaging and the question of neurodegeneration in schizophrenia. Progress in Neurobiology, 95(4), 514-516. Miguel-Hidalgo, J. J., X. A. Alvarez, et al. (2002). Neuroprotection by memantine against neurodegeneration induced by beta-amyloid(1-40). Brain Research, 958(1), 210-221. Miller, E. K. (2000). The prefrontal cortex and cognitive control. Nature reviews. Neuroscience, 1(1), 59-65.